Jamie’s Hodgkin’s lymphoma story defines what GRYT is.
Karen defines GRYT as a caregiver and shares about her daughter being diagnosed at 16 with ALL, a form of leukemia. She is now a childhood cancer advocate.
In February 2021, the FDA announced the approval of Onureg, a new oral formulation of a drug used for remission continuation therapy in adults with acute myeloid leukemia (AML). Gryt Health Chief Medical Officer breaks this down for our community.
Gryt Health Team member Christian shares his experience with Hodgkin’s lymphoma and why he is so committed to helping people who need support while tackling healthcare diagnoses.
Words cannot describe what an incredible woman Brooklyn is. Here is her story from CancerCon 2019. Still donning a feeding tube, she describes the challenges and feelings surrounding the decision to end treatment.
Patrick defines GRYT as a brain cancer survivor.
Cervical cancer couldn’t stop Sophie from defining what GRYT is.
In May 2021, Gryt Health announced our collaboration to improve bone health education publication being published in the Cancer Management and Research journal.
The Adolescent & Young Adult (AYA) age group is a niche population of the cancer community with special challenges and needs. Being diagnosed at that time presents unique experiences, but what happens when you become too old for that subset? We talked with survivors who are preparing to age out and those who have already aged out to work towards finding solutions to the gap in services between AYA and elderly. See what they had to say and add your 2 cents if you fit this description!